Letter: Rauwolfia derivatives and breast cancer.
D000959:Antihypertensive Agents / Q000009:adverse effects; D001943:Breast Neoplasms / Q000139:chemically induced* / Q000150:complications / Q000453:epidemiology; D005260:Female; D005387:Finland; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009378:Neoplasms, Multiple Primary / Q000139:chemically induced / Q000453:epidemiology; D009765:Obesity / Q000150:complications; D012110:Reserpine / Q000009:adverse effects* / Q000627:therapeutic use; D046948:Secologanin Tryptamine Alkaloids / Q000009:adverse effects*; D014481:United States
D000959:Antihypertensive Agents; D046948:Secologanin Tryptamine Alkaloids; D012110:Reserpine